Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy by Hongbo Zhang, Yu Xia, Chunqiu Yu, Huijie Du, Jinchang Liu, Hui Li, Shihui Huang, Qihua Zhu, Yungen Xu, Yi Zou

Subjects: Get full text

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection by Huilin Ou, Keda Chen, Linfang Chen, Hongcheng Wu

Subjects: “…PD-1/PD-L1…”
Get full text

Immunotherapy protocols in lung cancer by Nandini Menon, Sharada Mailankody

Subjects: Get full text

A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy by Yuanyuan Wang, Yuanyuan Wang, Tingxuan Gu, Tingxuan Gu, Xueli Tian, Xueli Tian, Wenwen Li, Ran Zhao, Ran Zhao, Wenqian Yang, Wenqian Yang, Quanli Gao, Tiepeng Li, Jung-Hyun Shim, Chengjuan Zhang, Kangdong Liu, Kangdong Liu, Mee-Hyun Lee, Mee-Hyun Lee, Mee-Hyun Lee

Subjects: Get full text

Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies by Yizhou Zhang, Ruicheng Wei, Ge Song, Xinyi Yang, Mengli Zhang, Wei Liu, Aiying Xiong, Xuehan Zhang, Qianhao Li, Wan-Jen Yang, Chencheng Han, Rui Liu, Chen Hu, Qingyu Wang, Jun Zhu, Yongqiang Shan

Subjects: “…Anti-PD-1/PD-L1…”
Get full text

Glucocorticoid and PD-1 Cross-Talk: Does the Immune System Become Confused? by Sabrina Adorisio, Lorenza Cannarile, Domenico V. Delfino, Emira Ayroldi

Subjects: “…PD-1/PD-L1…”
Get full text

Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis by Jue Zhu, Lifeng Yan, Qiming Wang

Subjects: “…PD-1/PD-L1 inhibitors…”
Get full text

A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China by Hongmei Li, Yuliang Yuan, Qianjie Xu, Guangzhong Liang, Zuhai Hu, Xiaosheng Li, Wei Zhang, Haike Lei

Subjects: Get full text

Data analysis of PD-1 antibody in the treatment of melanoma patients by Ting Li, Chao Zhang, Gang Zhao, Xinwei Zhang, Mengze Hao, Shafat Hassan, Min Zhang, Hong Zheng, Da Yang, Liang Liu, Farideh Mehraein-Ghomi, Xu Bai, Kexin Chen, Wei Zhang, Jilong Yang

Subjects: Get full text

Incidence risk of PD-1/PD-L1 related diarrhea in non-small cell lung cancer (NSCLC) patients: a systematic review and meta-analysis by Zhang C, Zhang S, Xu D, Liu R, Zhu Q, Zhao Y, Mao Y, Tian Y

Subjects: Get full text

Progress of Research on Programmed Death-1/Programmed Death Ligand-1 Inhibitors for HIV/AIDS with Cancer by DENG Changgang, ZHANG Wei, SUN Yanyu, LI Qisui, HUANG Wei, YUAN Jing

Subjects: “…pd-1/pd-l1 inhibitor…”
Get full text

Mechanism and Clinical Application of PD-1/PD-L1 Inhibitors in Immunotherapy by Yang Xicheng

Subjects: “…pd-1/pd-l1. tumor immunotherapy…”
Get full text

Effect of Rapamycin on Exosomes and PD-1/PD-L1 in Human Erythroleukemia HEL Cells by QI Lin, ZHANG Zhao, WANG Suyun, LIU Guimin, WANG Rui, FU Jianzhu, CHENG Zhiyong

Subjects: Get full text

The World of Immunotherapy Needs More Than PD-1/PD-L1—Two of the New Kids on the Block: LAG-3 and TIGIT by João Martins Gama, Paulo Teixeira, Rui Caetano Oliveira

Subjects: Get full text

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy by Lu Wen, Fan Tong, Ruiguang Zhang, Lingjuan Chen, Yu Huang, Xiaorong Dong

Subjects: Get full text

Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications by Vianey Rodriguez-Lara, Giovanny Soca-Chafre, Maria Rosa Avila-Costa, Juan Jose Juarez-Vignon Whaley, Jeronimo Rafael Rodriguez-Cid, José Luis Ordoñez-Librado, Emma Rodriguez-Maldonado, Nallely A. Heredia-Jara

Subjects: Get full text

Comparisons of Underlying Mechanisms, Clinical Efficacy and Safety Between Anti-PD-1 and Anti-PD-L1 Immunotherapy: The State-of-the-Art Review and Future Perspectives by Yating Zhao, Yating Zhao, Liu Liu, Liang Weng, Liang Weng, Liang Weng

Subjects: Get full text

Research progress of oncolytic virus combined with PD-1/PD-L1 inhibitors by GAN Zi-ying, TANG Hui

Subjects: “…pd-1/pd-l1|immune checkpoint inhibitor|oncolytic therapy…”
Get full text

An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor by Guiming Deng, Hao Sun, Rong Huang, Hongming Pan, Yanjiao Zuo, Ruihu Zhao, Zhongze Du, Yingwei Xue, Hongjiang Song

Subjects: Get full text

PD-L1 Status in Tenosynovial Giant Cell Tumors by Tulay Zenginkinet, Abdullahi Umar Faruq, Ayse Nur Toksoz Yildirim, Yusuf Iyetin, Burak Ozturan, Erhan Okay, Aykut Celik, Korhan Ozkan, Muhlik Akyurek

Subjects: Get full text